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SIRS, We are grateful to Qin and colleagues for their 
Comments on our systematic review examining the risk 
factors and impacts of psychological morbidity in young 
people with in━ammatory bowel disease (IBD). We 
agree that a complex inter-relationship is likely to exist 
between disease activity and its severity, illness percep- 
tions and psychological morbidity. Our systematic review 
synthesises the currently available evidence and suggests 
that this relationship extends further for young people 
with IBD, into other important areas of disease manage- 
ment, such as medication non-adherence. A comprehen- 
sive synthesis of the ボndings with statistical analyses,  
quoted from all included studies where available, is 
provided in our review. Detailed further information, 
including sample sizes is available in the supplementary 
on-line material. 
Our review outlines the possible impacts and risk factors  
for psychological morbidity in young people with 
IBD. This will aid healthcare professionals, is clinically 
important, and also increases understanding regarding 
the effect of psychological morbidity on the clinical end- 
points widely used in clinical trials to evaluate medical 
interventions. Although evaluation of the efボcacy of psy- 
chological treatments in adults and young people was not 
an objective of this review, we agree that further robust 
evaluation of psychological interventions, which currently 
show promise in young people with IBD, is needed. 
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